AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

OPKO Health Inc.

Report Publication Announcement • Jun 25, 2025

6963_rns_2025-06-25_f0b253cd-c15c-4ad4-90de-06d6ca21a9eb.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

MIAMI (June 25, 2025) – OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3 rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discussion moderated by Edward Tentoff, Managing Director, Senior Biotechnology Analyst. Investors can register for the symposium by contacting their Piper Sandler representative.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industryleading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.